Results 81 to 90 of about 1,509 (158)

Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome

open access: yesGynecological Endocrinology
In this article, we present a narrative review on the use of inositol in the treatment of polycystic ovary syndrome (PCOS). Of the different inositols that exist, only myo-inositol (MYO) and D-chiro inositol (DCI) have been studied in the treatment of ...
Iñaki Lete   +4 more
doaj   +1 more source

Effects of inositol in women with polycystic ovary syndrome: an umbrella review of meta-analyses from randomized controlled trials

open access: yesFrontiers in Endocrinology
ObjectivesThis umbrella review aimed to synthesize and appraise the evidence regarding the efficacy of inositol for Polycystic Ovary Syndrome (PCOS) by integrating meta-analyses of randomized controlled trials(RCTs), thereby assessing the robustness of ...
Mengxue Duan   +11 more
doaj   +1 more source

Management of polycystic ovary syndrome among Indian women using myo-inositol and D-chiro-inositol. [PDF]

open access: yesBioinformation, 2022
Vyas L   +6 more
europepmc   +1 more source

Effect of omega-3 and D-chiro inositol compared to D-chiro inositol alone on hormonal parameters in women with insulin resistant polycystic ovary syndrome

open access: yesInternational Journal of Reproduction, Contraception, Obstetrics and Gynecology
Background: Polycystic ovary syndrome (PCOS) is a common endocrine-metabolic disorder marked by high androgen levels, irregular ovulation, and ovarian cysts. Recommended treatments include lifestyle and nutrition changes alongside medication. Omega-3 fatty acids support immune function, insulin sensitivity, cell health, and ovulation.
Amitun Nessa   +7 more
openaire   +1 more source

Differential Gene Expression and Biological Analyses of Primary Hepatocytes Following D-Chiro-Inositol Supplement. [PDF]

open access: yesFront Endocrinol (Lausanne), 2021
Cheng F   +7 more
europepmc   +1 more source

Effect of 40:1 myo-inositol/D-chiro-inositol treatment on serum asprosin levels in polycystic ovary syndrome: a prospective randomized pilot study

open access: yesGinekologia Polska
OBJECTIVES: Asprosin, a novel adipokine primarily secreted by white adipose tissue, has been implicated in the pathogenesis of insulin resistance and metabolic dysfunction.
Ozlen Emekci Ozay   +4 more
doaj   +1 more source

Effects of Oral Supplementation with Myo-Inositol and D-Chiro-Inositol on Ovarian Functions in Female Long-Term Survivors of Lymphoma: Results from a Prospective Case-Control Analysis. [PDF]

open access: yesJ Pers Med, 2022
Dellino M   +18 more
europepmc   +1 more source

High Doses of D-Chiro-Inositol Alone Induce a PCO-Like Syndrome and Other Alterations in Mouse Ovaries. [PDF]

open access: yesInt J Mol Sci, 2021
Bevilacqua A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy